Jeremy Sherer and Amy Joseph discuss: The state law doctrine and the policy behind it How it may impact your business structure
Amy: Jeremy, a lot of our clients that come to us are founders who are new to healthcare. Can...more
Q4 2024 marked the conclusion of a turnaround year for life sciences venture investment. After two consecutive years of declining activity and macroeconomic uncertainty, the dust has settled, and investment is back on the...more
The Drug Enforcement Administration (DEA) has issued the “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” (Third Extension), which extends the flexibilities...more